Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAMTA2 antisense RNA 1 (CAMTA2-AS1) is a long non-coding RNA (lncRNA) gene locus identified in genomic proximity and antisense orientation to the CAMTA2 (Calmodulin binding transcription activator 2) coding gene. There is no current evidence in the biomedical literature that CAMTA2-AS1 encodes a therapeutic target, nor is its function, disease relevance, or pharmacological modulation established. Entries on bioinformatics portals confirm its annotation as a non-coding transcript with unknown function and no documented role in disease, therapy, or as a biomarker[5]. Note: The results above do not indicate this is a therapeutic target or a protein, receptor, enzyme, transporter, or similar druggable molecule at this time. Data on its biological or disease roles are not available. CAMTA2-AS1 should not be confused with CAMTA2, which encodes a protein transcription factor involved in various physiological processes in animals and plants[1][3][4]. No alternative names or known aliases for CAMTA2-AS1 were found in the available reference databases or literature[5].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CAMTA2 antisense RNA 1 (CAMTA2-AS1).